Biktarvy approved for the treatment of HIV-1 infection
The FDA has approved Biktarvy a once-daily single-tablet regimen for the treatment of HIV-1 infection...
List view / Grid view
The FDA has approved Biktarvy a once-daily single-tablet regimen for the treatment of HIV-1 infection...
Engineers have created a robot that can be used to help treat babies with a rare birth defect that affects an infant's oesophagus...
PET imaging may improve diagnosis and monitoring for MS patients...
A team of researchers set out to discover the disease pathways of a rare genetic kidney disease and consequently found a compound that stops the disease in its tracks.
Glatiramer acetate, a drug used to treat multiple sclerosis, has been found to have an effect on drug-resistant bacteria...
Researchers have collaborated to design a smart bandage that could eventually heal chronic wounds...
Leading organisations have developed specifications, which will promote more streamline and reproducible bioinformatics research for clinical trials...
Novartis announces CEO Joseph Jimenez to retire from Novartis in 2018. Vasant Narasimhan appointed CEO, effective February 1, 2018.
7 June 2017 | By Niamh Marriott, Junior Editor
Treatment with generic directly-acting antiviral drugs available in India increases lifespan while reducing lifetime health care costs